Q Fever News and Research

RSS

Attacks on WHO staff - progress on Marburg epidemic halted

The World Health Organization (WHO) has suspended its efforts to contain the outbreak of the deadly Marburg virus in Angola, in the northern province of Uige, after staff in their mobile surveillance vehicles have been attacked.

10 Apr 2005

Epstein-Barr virus may increase risk of lupus

Almost everyone has been infected with Epstein-Barr virus (EBV), a member of the herpes family and one of the most common human viruses.

7 Apr 2005

Fish oil, soluble fiber and antioxidants reduces need for traditional ulcerative colitis treatment

According to a study published in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, a nutritionally complete oral supplement enriched with fish oil, soluble fiber and antioxidants reduces reliance on traditional therapies for people with ulcerative colitis.

6 Apr 2005

Nasal filter new weapon against hay fever

The first clinical trial of a nasal filter has shown that they can significantly reduce both the number of people experiencing symptoms and the severity of their symptoms.

5 Apr 2005

When treating malaria is a waste of money

Africa may fail to benefit from new and better drugs for malaria because of massive misdiagnosis of the disease by health workers and patients.

5 Apr 2005

Obesity may hinder body's ability to control influenza infection

Obesity apparently reduces laboratory mice’s ability to turn on elements of their immune systems needed for controlling influenza infection, a new University of North Carolina at Chapel Hill School of Medicine study shows.

4 Apr 2005

Unravelling the Ebola virus’s biological cycle

Ebola virus infection in humans provokes a violent haemorrhagic fever. It usually flares up as intense epidemics. These kill 80 % of the people infected. Seven such outbreaks have hit Gabon and the Republic of Congo since 1994, leading to 445 cases resulting in 361 deaths.

4 Apr 2005

Tarvacin shows significant anti-viral activity

Peregrine Pharmaceuticals today announced that there will be two presentations, April 4 and 6, at the American Association of Immunologists (AAI) annual meeting in San Diego, California, indicating the anti-viral potential of its Tarvacin antibody. Dr. Melina Soares of The University of Texas Southwestern Medical Center at Dallas will present pre-clinical data titled "Targeting inside-out phospholipids on viruses in a guinea pig model of Lassa fever."

4 Apr 2005

First UK cases of previously rare disease reported in gay men

A previously rare disease has been reported for the first time in the UK, Lymphograunuloma venereum (LGV) is a genital/anogenital bacterial infection caused by a particularly invasive strain of Chlamydia trachomatis.

3 Apr 2005

CDC experts sent to Angola to help with Marburg epidemic

In an effort to control the Marburg virus outbreak in Angola, Health officials from the Centers for Disease Control and Prevention in Atlanta will assist the World Health Organization by going to Angola to help with outbreak investigation, infection control and laboratory diagnosis of the disease.

30 Mar 2005

REPLICor to disclose unique antiviral drug

REPLICor Inc., a privately owned biopharmaceutical company, is developing a broad spectrum antiviral drug called REP 9 which has the broadest spectrum of activity in vitro ever reported for a single chemical entity.

30 Mar 2005

High-rise homes have the highest levels of cockroach allergens

Roaches like to live high in the sky in places like Chicago, New York City and the Bronx, according to a recent study in the Journal of Allergy and Clinical Immunology. The study, conducted by an allergist affiliated with Children's Medical Center Dallas, found high-rise homes in Northeastern cities had the highest levels of cockroach allergens -- leading to a higher incidence of asthmatic episodes.

30 Mar 2005

Democratic Republic of Congo on alert for Marburg epidemic

Health officials in Angola are saying the outbreak of the Ebola-like Marburg virus has claimed a record toll of 126, but the government said the number of dead was lower.

29 Mar 2005

Bacteria's rising threat studied

Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA), and the number of asymptomatic individuals who harbor the organism in their bodies.

29 Mar 2005

Marburg death toll in Angola now up to 122

Carlos Alberto, a spokesman for the Angolan health ministry, says the death toll in the Marburg hemorrhagic fever outbreak in Angola has now risen to 122, just one fewer than in the largest previous outbreak of the disease, in the Democratic Republic of the Congo from 1998 to 200 and killed 123 of 149 people infected.

28 Mar 2005

Marburg Virus responsible for disease outbreak in Angola

The World Health Organization (WHO) announced yesterday that laboratory tests have shown that the cause of a hemorrhagic fever outbreak in northern Angola is the Marburg virus.

23 Mar 2005

Specific test key to determine whether or not allergy symptoms are really allergy-related

Many people with allergy-like symptoms could get the test they need, and the right treatments for their symptoms, from their primary care physician if managed care practice guidelines encouraged the use of the test.

23 Mar 2005

Miami baby possibly USA's 1st case of West Nile virus

West Nile Virus is a flavivirus commonly found in Africa, West Asia, and the Middle East and is related to the St. Louis encephalitis virus found in the United States. Preliminary tests suggest a 14-month-old baby hospitalized in Miami may be the nation's first case of West Nile virus this year.

22 Mar 2005

Fever outbreak in Angola causes concern

More than 90 people have died in Angola from what experts believe to be acute hemorrhagic fever syndrome.

22 Mar 2005

Drug-resistant bacteria MRSA a growing threat

Infectious diseases researchers at Vanderbilt University Medical Center are noticing a significant increase in the number of infections due to Methicillin-Resistant Staphylococcus Aureus (MRSA) and the number of asymptomatic individuals who harbor the organism in their bodies.

21 Mar 2005